Sharma, Sunny
Yang, Jun
Favate, John http://orcid.org/0000-0001-6344-4854
Shah, Premal http://orcid.org/0000-0002-8424-4218
Kiledjian, Megerditch http://orcid.org/0000-0001-8099-0451
Funding for this research was provided by:
Foundation for the National Institutes of Health (GM126488, GM124976)
Article History
Received: 19 December 2022
Accepted: 28 March 2023
First Online: 13 April 2023
Competing interests
: P.S. is a Director at Ananke Therapeutics, a Scientific Advisory Board member of Trestle Biosciences, and consults for Ribo-Therapeutics. All other authors declare no competing interests.